MKI67 and cancer: It is well known that Ki67 is a proliferative marker thus it is not hard to understand the reduction of which after NAC reflects a lower proliferation status of cancer cells and is related to a better prognosis.[42,43] Interestingly, we found that the prognosis of patients whose Ki67 increased after NAC was better than the unchanged patients, which seemed to be contradictory.